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Implantation of sterile foreign objects in the perito-
neal cavity of an animal initiates an inflammatory
response and results in encapsulation of the objects
by bone marrow-derived cells. Over time, a multilay-
ered tissue capsule develops with abundant myofibro-
blasts embedded in extracellular matrix. The present
study used the transgenic MacGreen mouse to char-
acterize the time-dependent accumulation of mono-
cyte subsets and neutrophilic granulocytes in the in-
flammatory infiltrate and within the tissue capsule by
their differential expression of the csf1r-EGFP trans-
gene, F4/80, and Ly6C. As the tissue capsule devel-
oped, enhanced green fluorescent protein-positive
cells changed from rounded to spindle-shaped mor-
phology and began to co-express the myofibroblast
marker -smooth muscle actin. Expression increased
with time: at day 14, 11.13  0.67% of tissue capsule
cells co-expressed these markers, compared with
50.77  12.85% of cells at day 28. The importance of
monocyte/macrophages in tissue capsule develop-
ment was confirmed by clodronate-encapsulated lipo-
some removal, which resulted in almost complete
abrogation of capsule development. These results
confirm the importance of monocyte/macrophages
in the tissue response to sterile foreign objects im-
planted in the peritoneal cavity. In addition, the in
vivo plasticity of peritoneal macrophages and their
ability to transdifferentiate from a myeloid to mesen-
chymal phenotype is demonstrated. (Am J Pathol
2010, 176:369–380; DOI: 10.2353/ajpath.2010.090545)
The tissue response to foreign materials including bioma-
terials and medical devices is known as the foreign body
response and is universally characterized by inflamma-
tory cell recruitment and subsequent encapsulation of the
foreign material by fibrotic tissue.1 At the site of implan-
tation an array of inflammatory mediators (and signaling
molecules) including cytokines, growth factors, extracel-
lular matrix proteins, and matrix-degrading enzymes cre-
ate a dynamic microenvironment that mediates a defined
sequence of events.2 In the initial acute inflammatory
phase, neutrophils are recruited to the surface of the
implanted materials, followed by lymphocyte and mono-
nuclear cell involvement and foreign body giant cell for-
mation (chronic inflammation). If the foreign material cannot
be removed, resolution of these inflammatory responses
occurs when a fibrous capsule has formed around it.3
Although the purpose of fibrous encapsulation is to iso-
late foreign material from the surrounding tissue, this
fibrotic tissue, along with foreign body giant cells at the
tissue/material interface, can significantly compromise
the efficiency of medical devices or prostheses and fre-
quently leads to device failure.
Our laboratory has observed a similar response to
foreign material implanted in the peritoneal cavity. Within
the first 3 to 5 days after implantation, the object is
covered by rounded cells, many of which have a macro-
phage-like morphology and express the common leuko-
cyte antigen Ly-5 (CD45).4 After 2 to 3 weeks, a tissue
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capsule comprising multiple layers of myofibroblasts and
extracellular matrix and covered by a continuous layer of
mesothelial cells surrounds the object.5 In contrast with
the tissue surrounding foreign material at other anatomi-
cal sites, the tissue encapsulating free-floating foreign
objects in the peritoneal cavity is avascular. On harvest,
the tissue has been used as an autologous graft for
replacement/repair of hollow smooth muscle organs
including blood vessels, bladder, vas deferens, and
uterus.5–7 Over the ensuing 2 to 3 months, the grafted
tissue undergoes further cell differentiation and tissue
remodeling to assume the morphology and function of
the host organ.8
In addition to providing a sterile location to develop myo-
fibroblast-rich tissue for engineering purposes, the perito-
neal cavity is a convenient site to investigate the involve-
ment of myeloid cells in the inflammatory response. The
mononuclear phagocyte system encompasses bone mar-
row precursors, peripheral blood monocytes, tissue macro-
phages, and dendritic cells, all of which express the mac-
rophage colony-stimulating factor receptor (csf1r).9–11
Macrophages also express F4/8012,13 and exhibit pheno-
typic and functional heterogeneity (reviewed in 14). Re-
cently, blood monocytes have also been shown to exhibit
heterogeneity in terms of expression of surface molecules
such as Gr1 (Ly6C), chemokine receptors (CX3CR1), and
migratory predisposition.15–17
Understanding the cellular processes involved in the
foreign body response is central to the development of
tissue engineering strategies using the resultant myofi-
broblast-rich tissue. It is also the key to maintaining the
integrity and function of biomedical implants such as
orthopedic implants, dental or breast implants, artificial
organs, vascular grafts, heart valves, renal dialyzers, and
controlled drug delivery systems. Thus, the aims of the
current study were to characterize the cells involved in
the inflammatory response to foreign objects implanted in
the peritoneal cavity and to determine whether monocyte/
macrophages are the source of peritoneum-derived tis-
sue capsule myofibroblasts. We have previously demon-
strated that myofibroblasts within the tissue capsule are
of bone marrow (hematopoietic) origin using sex-mis-
matched bone marrow transplant experiments.4 Others
have demonstrated that labeled peripheral blood mono-
nuclear cells, injected into the peritoneal cavity at the
same time as foreign object implantation, contribute to
tissue capsule formation.18 However, it is not clear
whether monocyte/macrophages are a cellular source
of tissue capsule myofibroblasts. Thus, we investi-
gated the hypothesis that in the peritoneal foreign body
response, monocyte/macrophages can transdifferenti-
ate to myofibroblasts.
For these investigations we used the transgenic MacGreen
mouse in which a promotor region of the c-fms (csf1r)
proto-oncogene directs myeloid-specific expression of
the reporter gene, enhanced green fluorescent protein
(EGFP).19,20 The c-fms gene encodes the receptor for the
cytokine CSF-1, which is essential for macrophage sur-
vival, proliferation, and differentiation. Our results dem-
onstrate that the inflammatory myeloid cells recruited
into the peritoneal cavity exhibit differential (bimodal)
expression of csf1r-EGFP; when used in conjunction
with markers F4/80 and Ly6C, the csf1r-EGFP reporter
provides a unique marker of monocyte/macrophage
subsets and neutrophilic granulocytes. We also show
that monocyte/macrophages within the tissue capsule
are capable of differentiating to a mesenchymal phe-
notype, evidenced by co-expression of myeloid (EGFP)
and myofibroblast (-smooth muscle [SM] actin) mark-
ers. These results provide evidence of the capacity for
fully differentiated macrophages to transdifferentiate and
suggest a greater potential for cellular plasticity than
recognized previously.
Materials and Methods
Mice
Male and female c-fms-EGFP (“MacGreen”) mice (in
which a 7.2-kb promoter element of the c-fms gene,
including the key enhancer, fms intronic regulatory ele-
ment, directs specific expression of EGFP in macro-
phage, trophoblast, and granulocyte lineages)19,20 and
wild-type (C57BL/6) control mice were purchased from
the Transgenic Animal Service of Queensland and the
University of Queensland Biological Resources, Univer-
sity of Queensland (St. Lucia, QLD, Australia). Mice were
used at the age of 8 to 16 weeks in all experiments and
maintained in our on-site animal facility according to in-
stitutional guidelines. All procedures were approved by
the University of Queensland Animal Ethics Committee
Guidelines and conform to the Animal Care and Protection
Act Qld (2002) and the Australian Code of Practice for the
Care and Use of Animals for Scientific Purposes (7th ed.,
2004) published by the Australian National Health and
Medical Research Council.
Foreign Objects
In this study, sterile cubes of boiled chicken egg white
(approximately 0.125 cm3) were used as foreign objects.
Egg white is composed predominantly of ovalbumin, an
avian protein not found in mammals. Because it is acel-
lular and almost 100% protein, it can be easily removed
during RNA isolation procedures. It can also be easily
fixed and sectioned for histological analysis of the encap-
sulating fibrotic tissue.
Surgical Procedure
Mice were anesthetized by inhalation of isoflurane (2% in
oxygen). Using sterile techniques, a 1-cm midline ab-
dominal incision was made, and the foreign objects (4
cubes of boiled egg white) were inserted into the perito-
neal cavity along with 1 ml of sterile 0.9% sodium chloride
(Baxter Healthcare, Sydney, Australia). The peritoneal
wall was closed with 4-0 Vicryl (Ethicon, Johnson & John-
son, Somerville, NJ), and the skin was sutured with 5-0
Sofsilk (Syneture, Mansfield, MA). In control animals
surgery was performed as above, but implantation of
the cubes of boiled egg white was omitted.
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Macrophage Depletion
Macrophage depletion was achieved using the “lipo-
some-mediated macrophage suicide technique.”21 Clo-
dronate-encapsulated liposomes are taken up by phago-
cytosis; clodronate is then released into the cell by
disruption of the phospholipid bilayers of the liposomes
and induces apoptosis of the macrophage.22 To elimi-
nate macrophages from the peritoneal cavity, mice re-
ceived i.p. injections of 0.1 ml of liposome-encapsulated
clodronate 2 days before implantation of cubes of boiled
egg white and then 2 and 4 days after the surgical
procedure. This ensured depletion of both resident peri-
toneal macrophages and recently recruited macro-
phages either from the omentum or circulating blood
monocytes.23 Clodronate was a gift from Roche (Mann-
heim, Germany) and incorporated into liposomes as pre-
viously described.21
Animal Sacrifice and Isolation of Cells
At various time points after implantation (days 2, 4, 7, 14,
21, and 28), mice were euthanized by carbon dioxide
inhalation. The peritoneal cavity was lavaged by introduc-
tion of 10 ml of ice-cold (4°C) calcium- and magnesium-
free Dulbecco’s PBS (Invitrogen, Eugene, OR). Peritoneal
exudate cells were collected into 15-ml centrifuge tubes
by puncturing the abdomen with an 18-gauge needle
(Becton Dickinson, San Jose, CA). Cubes of boiled egg
white and encapsulating tissue were removed and
placed in PBS (Invitrogen) for further processing; only
those that were free-floating and not attached to the
serosal surface were harvested for further analysis.
Collagenase Digestion of Tissue Capsule Cells
Single cell suspensions of tissue capsules were obtained
by enzymatic digestion in collagenase (3.5 mg/ml in
RPMI 1640, Worthington Biochemicals, Freehold, NJ) at
37°C for 1 hour. Cell suspensions were used for flow
cytometric analysis.
Flow Cytometry
To enumerate recruitment of cells into the peritoneal cav-
ity at various time points, absolute cell counts were de-
termined using Flow-Count Fluorospheres (Beckman
Coulter, Fullerton, CA) according to the manufacturer’s
guidelines and analyzed on an LSRII cytometer using
Diva software (version 6.1.1, Becton Dickinson). For cell
surface phenotyping, single-cell suspensions of perito-
neal exudates or tissue capsules (106 cells/tube) were
washed once in calcium- and magnesium-free PBS con-
taining 0.1% bovine serum albumin and 0.1% sodium
azide (PBA, Sigma-Aldrich, St. Louis, MO), pelleted, and
incubated with 5% rat serum (Sigma-Aldrich) in PBA for
30 minutes at 4°C. After washing, cells were incubated
with rat anti-mouse CD16/CD32 (2.4G2, Mouse BD Fc
Block) for 15 minutes before staining with R-phyco-
erythrin-conjugated anti-F4/80 (clone A3-1, Serotec, Ra-
leigh, NC), anti-CD45 (clone 30-F11), anti-Cd11b (clone
M1/70), anti-Gr1 (Ly6G/C, clone Rb6-8C5), or anti-Ly6G
(clone 1A8) (all obtained from BD Pharmingen, San Di-
ego, CA) or with Alexa Fluor 647-conjugated Ly6C (clone
ER-MP20, Serotec) for 30 minutes at 4°C, followed by
washing in PBA.
For intracellular staining, cells were fixed in 4% para-
formaldehyde (Electron Microscopy Sciences, Hatfield,
PA) for 10 minutes and permeabilized with 0.1% sapo-
nin (Sigma-Aldrich) for 5 minutes, followed by incubation
in PBS containing 5% donkey serum (Sigma-Aldrich) for
30 minutes at room temperature. Cells were then incu-
bated with rabbit monoclonal antibody to -SM actin
(Epitomics, Burlingame, CA) for 30 minutes at room tem-
perature, followed by Cy5-conjugated donkey anti-rabbit
IgG (Jackson ImmunoResearch Laboratories, West
Grove, PA). Immunostaining with the relevant isotype
controls was also performed to control for nonspecific
binding. Cells were analyzed on an LSRII cytometer us-
ing Diva software.
For cell sorting, isolated tissue capsule cells were sep-
arated on the basis of size/granularity (forward/side scat-
ter) and fluorescence intensity of EGFP, using FACSVan-
tage SE Diva and Diva software (version 5.2), according
to the manufacturer’s standard configuration.
Morphological Analysis with DIFF-Quik
For differential staining of fluorescence-activated cell
sorting (FACS)-separated tissue capsule cells, cytocen-
trifuged samples were stained with a DIFF-Quik stain set
(Lab Aids, Narrabeen, NSW, Australia) according to the
manufacturer’s instructions and mounted in mount-quick
(Daido Sangyo Co., Shinada, Japan). DIFF-Quik is a Ro-
manowsky-type stain that provides rapid histological
evaluation of peripheral blood and bone marrow smears.
With this technique, monocytes and granulocytes are
easily identified by their distinct nuclear and cytoplasmic
staining.24
Embedding and Tissue Sectioning
Tissue was OCT-embedded according to methods de-
scribed previously.19 Frozen sections (10-m-thick) were
cut using a Leica 3050 cryostat (Leica Instrument, Wet-
zlar, Germany) and collected directly onto SuperFrost
Plus glass slides (Menzel-Glaser, Braunschweig, Ger-
many). Slides were air-dried for 1 hour and then were
processed for immunofluorescence analysis.
Immunohistochemistry
Nonspecific binding was blocked by incubation of tissue
sections in blocking buffer (5% goat serum; Sigma-
Aldrich) and 1% bovine serum albumin (Sigma-Aldrich) in
PBS for 1 hour at room temperature. Sections were then
incubated with rabbit -SM actin monoclonal antibody
overnight at 4°C. Secondary staining was performed us-
ing an Alexa Fluor 594-conjugated goat anti-rabbit IgG
(Invitrogen) with incubation for 1 hour at room tempera-
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ture. Sections were counterstained with the nuclear dye
Hoechst 33342 (Invitrogen) and mounted in ProLong
Gold antifade reagent (Invitrogen).
Morphological Analysis of Tissue Capsules
To visualize EGFP expression by cells within tissue cap-
sules, frozen sections were counterstained with Hoechst
33342 and mounted in ProLong Gold antifade reagent.
Statistical Analysis
Data are presented as means  SD. PRISM software
(GraphPad Software, Inc., San Diego, CA) was used to
analyze differences between samples by one-way anal-
ysis of variance with Dunnett’s multiple comparison test.
For all experiments values of P  0.01 were considered
significant.
Results
Cell Recruitment to the Peritoneal Cavity After
Sterile Foreign Object Implantation
The implantation of foreign objects (sterile cubes of
boiled egg white) in the peritoneal cavity of MacGreen
and C57BL/6 (control) mice resulted in a significant in-
crease in the number of cells within the cavity at all time
points examined (days 2, 4, 7, 14, 21, and 28) compared
with that in the normal (“unstimulated”) peritoneal cavity
(P  0.01) (Figure 1). Cell numbers were maximal at day
7, with 51.6 8.8 106 cells within the cavity at this time.
The persistent inflammatory cell infiltrate occurred in re-
sponse to the implanted foreign objects, because sur-
gery alone elicited a short-lived inflammatory response,
which had resolved by day 7; at this time point the peri-
toneal cavity of “surgery alone” controls contained 10 
2.7 106 cells, not significantly different from the number
in the unstimulated peritoneal cavity (P  0.05).
Myeloid Cell Recruitment to the Peritoneal
Cavity After Sterile Foreign Object Implantation
FACS analysis showed that within the unstimulated peri-
toneal cavity of MacGreen mice, there were two distinct
populations of cells: EGFP-negative (EGFP) (57.6 
5.6%) and EGFP-positive (EGFP) (42.4  5.6%) (Figure
2A). The EGFP population was composed almost exclu-
sively of cells expressing high levels of EGFP (EGFPhi).
After implantation of foreign objects the proportion of
EGFP cells within the peritoneal exudate increased
markedly to 74.7  8.1% of total cells at day 2 after
implantation (Figure 2B). The EGFP population at this
time point exhibited marked heterogeneity in EGFP ex-
pression levels and could be divided into two subpopu-
lations, the EGFPhi population seen before implantation
and a second population of low EGFP-expressing cells
(EGFPlo). The proportion of the EGFPlo subset increased
with time after implantation to a maximum at day 7 (Figure
2C), comprising 52.3  7.4% of total EGFP cells, coin-
cident with maximal total cell numbers (shown in Figure
1); after this time, the proportion of EGFPlo cells de-
creased. At day 28 after implantation, EGFP cells still
contributed 63.7 4.8% of total cells within the peritoneal
0
10
20
30
40
50
60
70
0 2 4 7 14 21 28
da ys post-surge ry
to
ta
l c
el
ls
 (x
10
e-
6)
foreign objec t im plant
no im plant
*
*
*
*
*
* *
Figure 1. Cell recruitment to the peritoneal cavity after foreign object im-
plantation. Histogram shows total cell numbers (mean  SD) in the perito-
neal cavity before (day 0) and at various times after implantation of cubes of
boiled egg white. Surgery alone (no implantation) elicited a transient inflam-
matory response, which was ameliorated by day 7. *P  0.01 compared with
day 0 (n  9 mice for each time point from three independent experiments).
Figure 2. Myeloid cell recruitment to the peritoneal cavity after foreign
object implantation. Representative FACS profiles showing EGFP expression
by peritoneal exudate cells before (A) and at days 2 (B), 7 (C), or 28 (D) after
implantation of cubes of boiled egg white in the peritoneal cavity. E: Histo-
gram shows the proportion of EGFP, EGFPlo, and EGFPhi cells in the
peritoneal cavity before and after implantation. The EGFPlo subset was
observed from day 2 onward. Results are expressed as the mean % of total
cells (n  9 mice for each time point from three independent experiments).
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exudate, the majority of which were of the EGFPhi subset
(Figure 2D). The EGFP subset was also observed at all
time points after implantation, with proportions remaining
relatively constant throughout, from 25.3  8.1% of total
cells at day 2 to 36.4  6.8% at day 28 (Figure 2E).
Characterization of the Peritoneal Inflammatory
Cell Infiltrate
To characterize the cells involved in the inflammatory
response to foreign objects implanted in the peritoneal
cavity, peritoneal exudate cells were analyzed before
implantation and 2, 4, 7, 14, and 28 days after implanta-
tion by flow cytometry. At all time points examined,95%
of total cells (both EGFP and EGFP) were leukocytes,
identified by expression of CD45 (Figure 3A). The in-
volvement of myeloid cells was then investigated using
the markers CD11b and F4/80. Although CD11b is ex-
pressed by a number of cell types including monocyte/
macrophages, granulocytes, and lymphocytes,25,26 F4/80
is considered the most specific macrophage marker.12,13
Consistent with their identity as resident peritoneal macro-
phages, the majority of EGFP cells within the unstimulated
peritoneal cavity stained for both CD11b (myeloid cells)
(Figure 3B) and F4/80 (macrophages) (Figure 3C). The
EGFP subset never expressed F4/80, whereas a small
proportion of these cells did express CD11b and were most
likely lymphocytes.
The myeloid differentiation antigen Gr1 (Ly6C/G) is
expressed on granulocytes (neutrophils and eosinophils)
and monocytes and has recently been used to define
murine blood monocyte subsets.15 To gain further insight
into the inflammatory cells recruited into the peritoneal
cavity after foreign object implantation, we examined
whether short-lived Gr1 (Ly6C/G) blood monocyte sub-
sets described by Geissmann et al 15 were recruited to
the peritoneal cavity after foreign object implantation and
whether expression was restricted to either the EGFPhi or
EGFPlo subset. Two different monoclonal antibodies were
used in this study: clone RB6-8C5 that recognizes both
Ly6C and Ly6G,27 and ER-MP20, which recognizes only
the Ly6C antigen. As shown in Figure 3D, Gr1 cells were
not detected in the unstimulated peritoneal cavity, but a
small proportion (10.3  3.4% of total cells) of both the
EGFP and EGFP fractions was shown to be Ly6C
(Figure 3E). At 2 days after implantation of foreign ob-
jects, an influx of EGFP cells, which stained positive with
either Ly6C or Gr1, was observed. Three subsets of
Ly6C cells (EGFPloLy6Cmed-high, EGFPhiLy6Cmed, and
EGFPhiLy6Chi) (Figure 3F) and two subsets of Gr1 cells
(EGFPhiGr1hi and EGFPloGr1lo) (Figure 3G) were identi-
fied. Surprisingly, at this time point the majority of EGFP
cells in the inflamed peritoneal cavity expressed detect-
able F4/80, but levels were higher in the EGFPhi subset
(Figure 3H). A proportion of the EGFPhi subset did not
express F4/80, and these most likely represent granulo-
cytes newly recruited to the peritoneal cavity. Further
characterization of the different subsets was achieved by
costaining with F4/80 and Ly6C (Figure 3I), with the newly
recruited granulocytes represented in the upper left
quadrant (Ly6CF4/80) and mature macrophages in
the lower right quadrant (F4/80Ly6C). In agreement
with previous studies showing variable expression of
F4/80 by monocyte subsets,17 immature monocyte/mac-
rophages and granulocytes showed variable expression
levels of both F4/80 and Ly6C (upper right quadrant).
Figure 3. Characterization of the inflammatory in-
filtrate. Peritoneal exudate cells from the unstimu-
lated peritoneal cavity stained with CD45 (A),
CD11b (B) F4/80 (C), Gr1 (D), and Ly6C (E). After
implantation of cubes of boiled egg white, an in-
flux of Ly6C (F), Gr1 (G), and EGFPloF4/80
(H) cells was observed at day 2. F: Three subsets of
Ly6C-expressing cells observed at this time:
EGFPloLy6Cmed-high (pink), EGFPhiLy6Cmed (blue),
and EGFPhiLy6Chi (green).G: Two subsets of Gr1
cells: EGFPhiGr1hi (red) and EGFPloGr1lo (green).
Myeloid cells within the inflammatory infiltrate at
day 2 were further characterized by costaining
with F4/80 and Ly6C (I). An additional subset of
Ly6 cells (red) was observed at day 4 (J) and
exhibited physical features of inflammatory mono-
cytes (K). At day 7, peritoneal exudate cells
showed up-regulation of F4/80 (L), with concom-
itant down-regulated expression of Ly6C (M) and
Gr1 (N). Inflammatory cell recruitment had ceased
by day 14 with peritoneal exudate cells no longer
expressing Ly6C (O) and both subsets of EGFP
cells expressing F4/80 (P). For all profiles, the
forward scatter (FSC) and propidium iodide fluo-
rescence was used to gate out debris and dead
cells, respectively. In all panels, representative pro-
files are shown for n 6 mice per time point from
two independent experiments. SSC, side scatter.
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The cell populations in the peritoneal cavity changed
rapidly. By day 4, an additional Ly6C subset was iden-
tified, characterized by intermediate expression of EGFP,
very high Ly6C expression (Figure 3J), and low orthogo-
nal (side) scatter (indicating mononuclearity) (Figure 3K).
These cells would be considered the classic inflamma-
tory monocyte, analogous to those attracted by stimuli
such as thioglycollate broth. Concomitant with up-regu-
lated expression of F4/80 at day 7 (Figure 3L), Ly6C
(Figure 3M) and Gr1 (Figure 3N) were down-regulated on
all subsets except a small population of EGFPlo cells. At
this time 95% of EGFP cells expressed F4/80, provid-
ing evidence for a continuous maturation pathway of
recruited monocytes and possibly granulocytes to mac-
rophages. The inflammatory response had resolved by
day 14, evidenced by the absence of (newly recruited)
Ly6C cells in the peritoneal cavity (Figure 3O). In addi-
tion, the Ly6C expression observed on the EGFPlo subset
at day 7 was completely down-regulated. At this time all
EGFP cells expressed F4/80 (Figure 3P). The FACS
profiles for day 28 peritoneal cells (not shown) closely
resembled those for day 14.
Because the Gr1 (Ly6C/G) antigen is commonly used
to mark murine monocyte subsets and the current study
identified two subsets of Gr1 cells in the inflammatory
infiltrate, we used this antibody to sort the cells and then
confirm their identity based on morphology (Figure 4A).
Diff-QUIK staining of the EGFPloGr1lo subset revealed
that it was composed entirely of neutrophils, character-
ized by their pale-pink cytoplasmic staining (Figure 4B).
The EGFPhiGr1hi subset was composed almost exclu-
sively of polymorphonuclear-like ring cells (Figure 4C),
with a small number of ring-shaped mononuclear cells,
similar to those described by Biermann et al,28 also de-
tected. These cells may represent the Gr1 subset of in-
flammatory monocytes described by Geissmann et al.15
To investigate the observation that a proportion of the
EGFPlo subset of peritoneal exudate cells expressed
granulocyte-specific markers and exhibited morphologi-
cal features of polymorphonuclear cells, but also ex-
pressed the macrophage-specific marker F4/80, perito-
neal lavage cells were FACS-sorted based on EGFP and
F4/80 expression (Figure 4D). Morphological character-
ization of DIFF-Quik-stained cells confirmed that by day 2
inflammatory neutrophils express detectable F4/80 anti-
gen, albeit at lower levels than mature macrophages. The
EGFPlo F4/80lo subset contained neutrophils and mono-
cytes (Figure 4E), whereas macrophages at different de-
velopmental stages comprised the EGFPhi F4/80hi subset
(Figure 4F). This result is in agreement with our previous
demonstration that inflammatory neutrophils obtained 24
hours after peritoneal injection of thioglycollate broth can
acquire F4/80 and other macrophage-specific gene ex-
pression in vitro in response to CSF-1.20 The unequivocal
expression of F4/80 by neutrophils lends further support
to the possibility that neutrophils can transdifferentiate to
macrophages.
EGFP-Positive Cell Involvement in the
Developing Tissue Capsule
Confocal microscopy of tissue capsule sections showed
that at day 2 after implantation, the surfaces of implanted
cubes of boiled egg white collected from MacGreen mice
were covered by one to two layers of cells, most of which
had a rounded appearance and expressed EGFP (Figure
5A). By day 14, the object was completely encapsulated
by tissue, which was several cell layers thick, with the
majority of cells still expressing EGFP (Figure 5B). At this
time, EGFP cells with both rounded and spindle-shaped
morphologies were observed; rounded cells expressed
high levels of EGFP aggregated in the innermost layers of
the capsule, whereas the spindle-shaped cells were lo-
cated toward the periphery. By day 28, the capsule did
not seem to have increased in thickness, and EGFP
cells were still major contributors. Many spindle-
shaped cells were evident within the inner layers of the
capsule, some of which still expressed EGFP (Figure
5C). Rounded cells expressing high levels of EGFP
Figure 4. Morphological analysis of peritoneal la-
vage cells. Cells from the peritoneal cavity at day 2
after implantation stained for Gr1 (A) or F4/80 (D).
Morphological analysis (Diff-Quik) of FACS-sorted
EGFPloGr1lo (green) and EGFPhiGr1hi (red) subsets
shows neutrophils (B) and polymorphonuclear
leukocytes and mononuclear cells with ring-
shaped nuclei (arrow) (C), respectively. FACS-
sorted EGFPloF4/80lo cells were monocytes and
neutrophils (E), whereas the EGFPhiF4/80hi subset
comprised macrophages (F). Scale bars  10 m.
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were frequently observed on the surface of the tissue
capsule, suggesting that monocyte/macrophages were
still contributing to tissue capsule formation. Vasculariza-
tion of the tissue capsule was never observed. EGFP
expression was never detected in tissue capsules ob-
tained from C57BL/6 control mice (Figure 5D). Further-
more, tissue capsule development was identical in wild-
type and MacGreen mice, indicating that the csf1r-EGFP
transgene had no effect on the cellular response to the
implanted foreign objects.
FACS analysis of cells isolated from tissue capsules
showed that the proportion of EGFP cells in the tissue
capsule increased from 27.6  7.4% of total cells at day
2 to 68.1 6.9% at day 7 and remained elevated through
to day 28 when they constituted 61.9  10.6% of total
cells (Figure 5E). EGFP cells also contributed to tissue
capsule development, and morphological analysis re-
vealed that this subset comprised mainly mast cells and
lymphocytes (data not shown). As observed for post-
implantation peritoneal exudate cells, tissue capsule
cells showed heterogeneity in EGFP expression levels,
although the proportions of EGFPlo and EGFPhi cells var-
ied and the distinctions between the two subsets was not
clearly defined at the later stages of capsule develop-
ment. At day 2, the majority of EGFP cells were of the
EGFPhi phenotype with the EGFPlo subset comprising
9.7  1.4% of total cells (Figure 5F). The distinction
between the two subsets became clearly evident at day 7
with the EGFPlo and EGFPhi populations comprising 24
6.8 and 44 5.7% of total cells, respectively (Figure 5G).
From this time on the two subsets appeared to merge,
with increasing EGFP expression possibly indicating dif-
ferentiation/maturation of recruited monocytes and gran-
ulocytes (EGFPlo) to macrophages (EGFPhi) (Figure 5H).
By day 28, the majority of cells were of the EGFPhi phe-
notype and the two subsets could not be clearly sepa-
rated (Figure 5I).
Characterization of Tissue Capsule Cells
To further characterize the cells involved in tissue cap-
sule formation, single-cell suspensions were prepared
from tissue capsules at days 2, 4, 7, 14, and 28 after
implantation and expression of myeloid markers was an-
alyzed by FACS. For all markers, tissue capsule cells
displayed a pattern of expression similar to that observed
for peritoneal exudate cells. At all time points, the majority
of tissue capsule cells expressed CD45, with the excep-
tion of a small subset of EGFP cells (Figure 6A). The
majority of EGFP cells also expressed the macrophage
marker F4/80 (Figure 6B). As described for peritoneal
exudate cells, monocyte-to-macrophage maturation was
indicated by up-regulation of EGFP and F4/80 over time.
At day 28, F4/80 macrophages still contributed 50 
6.7% of total cells (Figure 6C), confirming confocal mi-
croscope images showing EGFP cells with macro-
phage-like morphology within the tissue capsule at this
time point (Figure 5C).
Immunostaining with Gr1 and Ly6C antibodies identi-
fied an influx of Ly6C (Figure 6D) and Gr1 (Figure 6E)
cells during early tissue capsule development, with max-
imal numbers at day 4. By day 7, there was an increase
in the proportion of EGFPlo Ly6C cells, but as observed
for peritoneal exudate cells the down-regulation of Ly6C
expression by the EGFPhi subset had commenced (not
shown). Ly6C (and Gr1) expression was down-regulated
on all EGFP subsets by day 14 (Figure 6F), and no
further recruitment of Ly6C cells occurred after this
time. Morphological analysis of FACS-sorted EGFP sub-
Figure 5. EGFP cells contribute to tissue cap-
sule development. EGFP (green) expression by
cells within the developing tissue capsule in
MacGreen mice at day 2 (A), day 14 (B), and day
28 (C) after implantation of sterile cubes of
boiled egg white. D: Lack of EGFP expression in
the day 14 tissue capsule from the C57/BL6 con-
trol; nuclei are counterstained with Hoechst
33342 (blue). Scale bars  20 m. E: Histogram
shows the proportions of EGFP, EGFPlo, and
EGFPhi cells within the capsule at the indicated
time points. Representative FACS profiles of tis-
sue capsule cells at day 2 (F), day 7 (G), day 14
(H), and day 28 (I). Results from n  9 mice
from three independent experiments.
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sets from the day 28 tissue capsule identified monocyte/
macrophages and neutrophils in the EGFPlo subset (Fig-
ure 6G) and macrophages, multinucleated giant cells,
and other large cells, most likely myofibroblasts, within
the EGFPhi fraction (Figure 6H).
Macrophages Are Essential for Tissue Capsule
Development
The abundance of macrophages within the tissue cap-
sule at all time points led us to investigate the importance
of these cells in capsule development. Depletion of both
peritoneal macrophages and recently recruited blood
monocytes with liposome-encapsulated clodronate was
confirmed by FACS analysis of peritoneal lavage cells
from clodronate-treated mice, which showed a marked
reduction in total EGFP cells compared with PBS lipo-
somes or no-injection controls (data not shown). FACS
analysis of tissue capsule cells at days 7 (Figure 7A) and
14 (Figure 7B) demonstrated a significant reduction in
total EGFP cells. At day 7, clodronate-encapsulated
liposomes caused 35.8 and 76.8% reductions in the pro-
portion of EGFPlo and EGFPhi cells, respectively. The
effect was more pronounced at day 14, with almost com-
plete ablation of both EGFP subsets: a 73.3% reduction
in the EGFPlo subset and a 97.9% reduction in the EGFPhi
subset. PBS liposome control injections (Figure 7C) did
not cause a significant change in the EGFP expression
profile of tissue capsules from MacGreen mice compared
with the no-injection controls (Figure 7D).
Histological analysis of tissue capsule sections
showed a marked reduction in capsule development in
clodronate-treated mice; at both days 7 and 14, the cap-
sules consisted of only a monolayer of elongated me-
sothelial-like cells (Figure 7E). Conversely, in animals that
received empty (PBS) liposomes, tissue capsule devel-
opment resembled that in untreated mice. As shown in
Figure 7F, the day 14 capsules from PBS liposome-
treated mice comprised multiple layers of rounded and
spindle-shaped cells overlaid by a single layer of me-
sothelial-like cells. Taken together, these findings con-
firm the necessity for macrophages in tissue capsule
development.
Macrophage Transdifferentiation into Tissue
Capsule Myofibroblasts
Given the prevalence of macrophages within the tissue
capsule through to day 28, along with previous research
showing the hematopoietic origin of capsular myofibro-
blasts,4 we sought to determine whether cells of myeloid
origin (ie, monocyte/macrophages expressing EGFP)
within the tissue capsule can transdifferentiate into -SM
actin-expressing myofibroblasts. We reasoned that such
cells would retain the stable EGFP protein even if tran-
scription of macrophage-specific genes was extin-
guished. Flow cytometric analysis of cells isolated from
tissue capsules showed that at day 14, 12.7  0.5% of
total cells expressed the myofibroblast marker -SM actin
and nearly 85% of these co-expressed EGFP. At day 21,
23  4.8% of cells expressed -SM actin, and at day 28,
63  14.5% of total cells expressed -SM actin with
Figure 6. Characterization of tissue capsule cells. Dot plots from FACS
analysis of cells from day 7 tissue capsules immunostained for CD45 (A) or
F4/80 (B) and from day 28 tissue capsules stained for F4/80 (C). Ly6C (D)
and Gr1 (E) cells were involved in tissue capsule development and were
maximal at day 4 but were reduced in number by day 14 (F). Morphological
analysis of the day 28 EGFPlo and EGFPhi subsets identified neutrophils and
monocytes (G) and macrophages and multinucleated giant cells (H), respec-
tively. Scale bars 20 m. FACS profiles are representative of n 6 mice for
each time point from two independent experiments.
Figure 7. Macrophages are essential for tissue capsule development.
Histograms show reduction in total EGFP cells in tissue capsules from
clodronate-liposome-treated MacGreen mice at days 7 (A) and 14 (B) after
implantation of sterile cubes of boiled egg white. Representative day 14
tissue capsule profiles show that PBS liposomes did not elicit a reduction
in EGFP cells within the tissue capsule (C) compared with the no-
injection control (D). Representative images of tissue capsules from clo-
dronate-liposome treated (E) and PBS control (F) MacGreen mice at day
14. Scale bars  10 m.
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80% of these cells co-expressing EGFP (Figures 8, A
and B).
The presence of cells within the tissue capsule that
co-express EGFP and -SM actin was confirmed by im-
munohistochemical analysis. Within the day 14 tissue
capsule, the majority of cells co-expressing EGFP and
-SM actin exhibited the rounded morphology of macro-
phages, with a small proportion exhibiting an elongated
morphology (Figures 8, C and D). By day 28, an in-
creased proportion of cells co-expressing both markers
was observed, and the majority of these exhibited a
spindle-shaped morphology (Figure 8, E and F). These
results support the hypothesis that macrophages within
the capsule transdifferentiate into myofibroblasts.
Discussion
The peritoneal foreign body response has been used by
our laboratory to produce tissue suitable for replacement/
repair of damaged smooth muscle organs. This response
resembles that described previously for experimental
models of induced inflammation and the response to
biomaterials in which the physical and chemical prop-
erties of the material modulate the precise cellular
events.3,29 The present study shows that the cellular re-
sponse to boiled egg white is similar to that previously
reported by our laboratory and others for a variety of
foreign materials implanted in the peritoneal cavity, in-
cluding boiled blood clot,30 silastic tubing,5,18 poly(lactic
acid) scaffolds,31 and acellular photo-oxidized bovine
pericardium patches.32 Given that the foreign object re-
mains free-floating within the peritoneal cavity, our exper-
imental model also provides a means by which to study
the cells involved in the sterile inflammatory response
without contamination by surrounding tissue. The present
study confirms the central role of myeloid cells in the
production of tissue that encapsulates foreign objects in
the peritoneal cavity and further provides definitive evi-
dence that monocyte/macrophages are able to transdif-
ferentiate in vivo to a myofibroblastic phenotype. Al-
though the primary focus of this study was to investigate
the involvement of myeloid cells in the peritoneal foreign
body response, the presence of nonmyeloid (EGFP)
cells, including lymphocytes, was also observed in
tissue capsule development. This finding is in agree-
ment with results of other studies demonstrating the
involvement of lymphocytes in the tissue response to
foreign materials.33–35
We demonstrate that implantation of sterile foreign ob-
jects in the peritoneal cavity initiates an inflammatory
response in which EGFP Gr1 (Ly6C) monocytes and
granulocytes are rapidly recruited to the peritoneal cavity
and encapsulate the foreign object. Morphological anal-
ysis shows that the EGFP Gr1 (Ly6C) cells, which
enter the peritoneal cavity and encapsulate the implanted
object in the early phase (at day 2), are primarily
granulocytes, with monocytes representing only a mi-
nor subset. However, many of these cells also express
the macrophage-specific F4/80 antigen, suggesting that
monocytes and granulocytes may not represent two dif-
ferent lineages but rather different stages of a single
lineage. As the inflammatory response progresses, ex-
pression of Ly6C by monocytes and granulocytes is
down-regulated, with concomitant up-regulation of F4/80
and the csf1r-EGFP transgene such that F4/80 macro-
phages become the predominant cell type within the
Figure 8. Macrophage-to-myofibroblast transdifferentiation within the tissue capsule. A: Histogram shows the proportions of total cells expressing -SM actin
(alone or co-expressing EGFP) within the tissue capsule at days 14, 21, and 28. B: Representative FACS profile of -SM actin expression by day 28 tissue capsule
cells. C: Photomicrographs show expression of EGFP (green) and -SM actin (red) in day 14 tissue capsules. D: Higher magnification shows cells of rounded
morphology (arrows) and elongated cells (asterisk) co-expressing EGFP and -SM actin. E: Many elongated cells co-expressing EGFP and -SM were observed
at day 28. F: Higher magnification. Nuclei counterstained with Hoechst 33342 (blue). Scale bars  20 m. Representative images are from n  6 mice for each
time point, from two independent experiments.
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peritoneal cavity and the tissue capsule. Thus, we pro-
pose that at least some of the so-called “short-lived”
Gr1 subset may not undergo apoptosis to be replaced
by a second wave of newly recruited monocytes but
instead transdifferentiate to F4/80loGr1 monocytes. Al-
though this hypothesis needs further investigation, it is
supported by previous research showing that the csf1r-
EGFP reporter is also expressed by Gr1 granulocytes in
MacGreen mice and that inflammatory neutrophils can
express macrophage-specific genes.20 In response to an
array of cytokines including granulocyte-macrophage
colony-stimulating factor, tumor necrosis factor-, and
CSF-1, human neutrophils have also been shown to
differentiate into macrophages in vitro.36 By day 28,
mature “resident-like” macrophages (Gr1EGFPhiF4/
80hi) are the predominant cell type within the peritoneal
cavity and the tissue capsule, with a smaller subset of
Gr1EGFPloF4/80lo cells, comprising predominantly
monocytes, also present.
The persistence of macrophages within the tissue cap-
sule surrounding the foreign object is a key feature of the
inflammatory response to implanted materials.29 In our
experimental model, the EGFP subsets of the day 28
tissue capsule include macrophages, multinucleated gi-
ant cells, and a small number of neutrophils, although
many cells with spindle-shaped myofibroblastic morphol-
ogy are also present. The importance of macrophages in
capsule development was confirmed by clodronate-en-
capsulated liposome-mediated depletion experiments,
which almost completely abrogated tissue capsule de-
velopment. In this study, we showed that intraperitoneal
injections of clodronate-encapsulated liposomes elimi-
nated both resident peritoneal macrophages and re-
cently recruited monocytes. Not surprisingly, this treat-
ment also almost completely removed the EGFPlo subset,
which is composed of predominantly polymorphonuclear
neutrophils that also have phagocytic capabilities. It is
important to note that this route of administration has
been shown to deplete macrophages in spleen, lymph
nodes, and liver.23 These results indicate that macro-
phages are essential for development of the multilayered
tissue capsule suitable for replacement/repair of smooth
muscle organs.5
As a central finding, we show that from day 14 onward
the developing tissue capsule contains a subset of
EGFP cells that co-express -SM actin, increasing with
time to comprise 80% of total -SM actin cells within
the capsule at day 28. In addition, with progressive de-
velopment of the tissue capsule the morphology of
EGFP -SM actin cells changed from a rounded mac-
rophage-like appearance to a more spindle-shaped myo-
fibroblastic phenotype. Taken together, these results pro-
vide definitive evidence that monocyte/macrophages are
capable of transdifferentiating to myofibroblasts. The re-
tention of EGFP expression by these “transdifferentiated”
myofibroblasts is most likely due to the relatively long
half-life of the EGFP protein. These results confirm earlier
electron microscopic studies, which reported the pres-
ence of cells intermediate in morphology between mac-
rophage and fibroblast/myofibroblast within the tissue
capsule30 and provide evidence that the hematopoietic
progenitor of the myofibroblast is the macrophage.4
Macrophages have many trophic roles in development
and are essential for effective tissue regeneration.37 Al-
though the role of macrophages was previously attrib-
uted to the paracrine production of cytokine/growth fac-
tors and extracellular matrix proteins to recruit and
support other cell types,2,38 the present study provides
evidence for a more direct role in this process by way of
their capacity to transdifferentiate into myofibroblasts.
The ability of macrophages to transdifferentiate to fibro-
blasts has been documented previously,39,40 with cul-
tured peritoneal macrophages from Schistosoma mansoni
chronically infected mice exhibiting fibroblast-like char-
acteristics and co-expressing the fibroblast (procollagen)
and macrophage (mac-1/mac-2) markers. Thioglycollate-
stimulated peritoneum-derived macrophages have also
been shown to transdifferentiate into smooth muscle-like
cells/myofibroblasts in response to transforming growth
factor-, evidenced by up-regulation of smooth muscle/
myofibroblast markers such as calponin and -SM actin
and concomitant down-regulation of the macrophage
marker CD11b.41 The bidirectionality of macrophage-
myofibroblast-smooth muscle cell transdifferentiation of
these two cell types is suggested by the demonstration
that smooth muscle cells adopt a macrophage-like phe-
notype after in vitro cholesterol loading.42
The possibility that peritoneal macrophages partici-
pating in the peritoneal foreign body response have the
capacity to transdifferentiate was first proposed in
1972 by Kouri and Ancheta,43 who demonstrated the
presence of cells with intermediate morphologies be-
tween macrophages and fibroblasts within tissue cap-
sules that formed around Epon lamina implants. Likewise
our laboratory identified macrophage-fibroblast interme-
diary cells in the tissue capsule around free-floating in-
traperitoneal blood clots, lending further support to the
transdifferentiation capacity of peritoneal macrophages.30,44
More recently, Jabs et al18 showed that PKH-26-la-
beled peripheral blood mononuclear cells injected into
recipient animals before foreign object implantation
incorporated into the tissue capsule and that from day
14 onward, a proportion of -SM actin-expressing spin-
dle-shaped cells co-expressed macrophage markers
(ED1/ED2). The present study corroborates and extends
these in vivo studies and demonstrates that inflammatory
tissue macrophages are capable of acquiring the char-
acteristics of myofibroblasts, including the expression of
-SM actin.
These findings indicate a greater cellular plasticity for
myeloid cells than previously envisaged and suggest that
within its lifetime, a single cell has the capacity to adopt
a range of phenotypes and functions according to phys-
iological needs. The results presented here suggest a
continuum from monocyte (or granulocyte) through mac-
rophage to myofibroblast. Indeed our previous studies
indicate that when subjected to the appropriate environ-
mental cues, such as hemodynamic factors and active
stretch,45 these cells have the capacity to differentiate
even further. For example, when tubes of this myofibro-
blast-rich tissue (formed around a tubular molding im-
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planted into the peritoneal cavity for 2 to 3 weeks) are
grafted into an autologous artery to replace excised seg-
ments, the tissue develops the characteristics of mature
vascular smooth muscle and constituent cells express
smooth muscle differentiation markers including smooth-
elin and the smooth muscle myosin isoform SM-2.6,7
We present here a thorough cellular characterization of
the myeloid cells involved in the inflammatory response to
implanted foreign material. Specifically, we show that
after the initial recruitment of monocytes and granulo-
cytes, macrophages become the predominant cell within
both the peritoneal cavity and the tissue capsule. Further-
more, the results provide evidence to suggest that in
addition to the established monocyte-to-macrophage dif-
ferentiation, there is a continuous pathway of maturation
from granulocyte through monocyte/macrophage and
further to myofibroblast. These results question the tradi-
tional notion of distinct terminally differentiated cell types
with specific functions. We propose that, at least for some
cell lineages, cellular identity is more fluid than recog-
nized previously and that cells may adapt their pheno-
type and function according to local environmental cues.
Understanding the mechanisms regulating this process
may be the key to advances in tissue engineering.
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